ArticleJournal of clinical medicine2025
Impact of Tumor Necrosis Factor Antagonist Therapy on Circulating Angiopoietin-like Protein 8 (ANGPTL8) Levels in Crohn's Disease-A Prospective Multi-Center Study.
Mohammad Shehab, Sharifa Al-Fajri, Ahmed Alanqar, Mohammad Alborom, Fatema Alrashed, Fatemah Alshammaa, Ahmad Alfadhli, Sriraman Devarajan, Irina Alkhairi, Preethi Cherian and 3 more
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Mohammad ShehabDivision of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer, University Hospital, Kuwait University, Jabriya 47060, Kuwait.ORCID 0000-0003-2084-3956 Sharifa Al-FajriDivision of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer, University Hospital, Kuwait University, Jabriya 47060, Kuwait.
Ahmed AlanqarSchool of Medicine Building, Faculty of Medicine, Royal College of Surgeons in Ireland, Busaiteen 15503, Bahrain.
Mohammad AlboromDivision of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer, University Hospital, Kuwait University, Jabriya 47060, Kuwait.
Fatema AlrashedDepartment of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Jabriya 13110, Kuwait.ORCID 0000-0003-4020-5978 Fatemah AlshammaaDivision of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer, University Hospital, Kuwait University, Jabriya 47060, Kuwait.
Ahmad AlfadhliDivision of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer, University Hospital, Kuwait University, Jabriya 47060, Kuwait.
Sriraman DevarajanDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman, Kuwait City 15462, Kuwait.ORCID 0000-0001-6401-133X Irina AlkhairiDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman, Kuwait City 15462, Kuwait.ORCID 0000-0002-3547-9926 Preethi CherianDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman, Kuwait City 15462, Kuwait.
Jehad AbubakerDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman, Kuwait City 15462, Kuwait.ORCID 0000-0003-0681-7305 Mohamed Abu-FarhaDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman, Kuwait City 15462, Kuwait.ORCID 0000-0001-8357-1252 Fahd Al-MullaDepartment of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman, Kuwait City 15462, Kuwait.ORCID 0000-0001-5409-3829 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ANGPTL8CDinfliximab
Identifiers
PMID40725697
PMCPMC12295380
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390